MagnaPharm and CEMAG Care have entered into a Distribution Agreement for NEXAG® product in Poland, Romania & Hungary and first refusal right covering 10 additional CEE countries. MagnaPharm is strategically focussing on the importance of improving women patients' access to innovating and effective products in the field of gynaecology. MagnaPharm is one of leading players in both, Rx and OTC segments of pharmaceutical market in CEE and offers an excellent platform to successfully launch NEXAG®.

“We are very glad to announce our partnership with CEMAG Care. For several years MagnaPharm has a leading presence in the Gynaecology therapeutic segment in targeted CEE markets. Our Partnership with CEMAG will enable us to enrich our existed portfolio and grow in the CEE pharmaceutical market. We look forward to working with CEMAG Care in increasing standards of women’s care”.

Karol Michalak, CEO MagnaPharm

About MagnaPharm

MagnaPharm is a premier pharmaceutical and consumer healthcare service provider in Central & Eastern Europe. MagnaPharm is the partner of choice on the Central and Eastern Europe pharmaceutical market, offering a unique and full range of services on the distribution, marketing, sales, pharmaceutical retail, market access, pricing, and medical services segments. MagnaPharm is going an extra mile to fulfil the demands of its reputable partners, multinational and specialty international pharmaceutical companies that have decided not to operate directly in CEE or already operating in CEE but outsourcing parts of their portfolios. MagnaPharm operates in all main CEE countries: Romania, Bulgaria, Poland, Hungary, Czech Republic, Slovakia, Serbia, Slovenia, Lithuania, Estonia, Latvia, Croatia, Bosnia, Albania, Montenegro, Kosovo and North Macedonia.

For more info about MagnaPharm, please visit:  www.magnapharm.eu

“We are very enthusiastic about starting our collaboration with MagnaPharm to bring in CEE markets, NEXAG® an original an unique formulation of tranexamic acid indicated in the treatment of heavy menstrual bleeding. By sharing the same vision about empowering women’s health, MagnaPharm is a strategic partner to extend our presence in Europe to help women struggling with debilitating periods”

Clémence Desjardin, COO at CEMAG Care

About CEMAG CARE

CEMAG Care is a French pharmaceutical company founded in 2016 by André Ulmann dedicated to women’s health developing and commercializing innovative drugs and medical devices. CEMAG CARE’s mission is to break boundaries in women’s health by proposing therapeutic solutions prioritizing women’s well-being and comfort that address specific, unmet and often overlooked areas including contraception, abortion and menstrual health.

For more information about CEMAG CARE, please visit: https://cemagcare.com/en/home/